← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 20, 2018Last known activity
Mar 31, 2022
Timeline
2010s
- Jun 1, 2016
AiVita Biomedical, Inc.— Founded
Drugs by trial phase (5 distinct, 7 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (15)
- NCT05100641Study chairPhase 3Mar 31, 2022
- NCT05100641Lead sponsorPhase 3Mar 31, 2022
- NCT05007496CollaboratorPhase 2Apr 14, 2021
- NCT05007496Lead sponsorPhase 2Apr 14, 2021
- NCT04685603CollaboratorPhase 1Dec 7, 2020
- NCT04690387Study chairPhase 1Dec 7, 2020
- NCT04690387Lead sponsorPhase 1Dec 7, 2020
- NCT04685603CollaboratorPhase 1Dec 7, 2020
- NCT04690387CollaboratorPhase 1Dec 7, 2020
- NCT04386252Lead sponsorPhase 1/Phase 2Sep 30, 2020
- NCT04386252Study chairPhase 1/Phase 2Sep 30, 2020
- NCT03743298Study chairPhase 1Jun 30, 2019
- NCT03743298Lead sponsorPhase 1Jun 30, 2019
- NCT03400917Lead sponsorPhase 2Jun 20, 2018
- NCT03400917Study chairPhase 2Jun 20, 2018
Details
- Founded
- Irvine, CA, US Jun 1, 2016
- Last known activity
- Mar 31, 2022